These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 12365022)

  • 1. Inhibition of proliferation in human MNNG/HOS osteosarcoma and SK-ES-1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone: effects on insulin-like growth factor II.
    Braczkowski R; Schally AV; Plonowski A; Varga JL; Groot K; Krupa M; Armatis P
    Cancer; 2002 Oct; 95(8):1735-45. PubMed ID: 12365022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor.
    Plonowski A; Schally AV; Letsch M; Krupa M; Hebert F; Busto R; Groot K; Varga JL
    Prostate; 2002 Aug; 52(3):173-82. PubMed ID: 12111694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonists of growth hormone-releasing hormone inhibit the proliferation of experimental non-small cell lung carcinoma.
    Szereday Z; Schally AV; Varga JL; Kanashiro CA; Hebert F; Armatis P; Groot K; Szepeshazi K; Halmos G; Busto R
    Cancer Res; 2003 Nov; 63(22):7913-9. PubMed ID: 14633721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of growth of human osteosarcomas by antagonists of growth hormone-releasing hormone.
    Pinski J; Schally AV; Groot K; Halmos G; Szepeshazi K; Zarandi M; Armatis P
    J Natl Cancer Inst; 1995 Dec; 87(23):1787-94. PubMed ID: 7473836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of receptors for growth hormone-releasing hormone in human osteosarcomas and Ewing's sarcomas.
    Halmos G; Schally AV; Bernardino AL; Varga JL
    Int J Oncol; 2006 Aug; 29(2):463-9. PubMed ID: 16820890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonists of growth hormone-releasing hormone (GH-RH) inhibit IGF-II production and growth of HT-29 human colon cancers.
    Szepeshazi K; Schally AV; Groot K; Armatis P; Halmos G; Herbert F; Szende B; Varga JL; Zarandi M
    Br J Cancer; 2000 May; 82(10):1724-31. PubMed ID: 10817510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor effect of nutrient synergy on human osteosarcoma cells U-2OS, MNNG-HOS and Ewing's sarcoma SK-ES.1.
    Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
    Oncol Rep; 2005 Feb; 13(2):253-7. PubMed ID: 15643507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonists of growth hormone-releasing hormone and somatostatin analog RC-160 inhibit the growth of the OV-1063 human epithelial ovarian cancer cell line xenografted into nude mice.
    Chatzistamou I; Schally AV; Varga JL; Groot K; Armatis P; Busto R; Halmos G
    J Clin Endocrinol Metab; 2001 May; 86(5):2144-52. PubMed ID: 11344219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonists of growth hormone-releasing hormone arrest the growth of MDA-MB-468 estrogen-independent human breast cancers in nude mice.
    Kahán Z; Varga JL; Schally AV; Rékási Z; Armatis P; Chatzistamou L; Czömpöly T; Halmos G
    Breast Cancer Res Treat; 2000 Mar; 60(1):71-9. PubMed ID: 10845811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of recombinant human insulin-like growth factor I and II (IGF-I/-II) and growth hormone (GH) on the growth of normal adult human osteoblast-like cells and human osteogenic sarcoma cells.
    Scheven BA; Hamilton NJ; Fakkeldij TM; Duursma SA
    Growth Regul; 1991 Dec; 1(4):160-7. PubMed ID: 1842348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138.
    Heinrich E; Schally AV; Buchholz S; Rick FG; Halmos G; Mile M; Groot K; Hohla F; Zarandi M; Varga JL
    Prostate; 2008 Dec; 68(16):1763-72. PubMed ID: 18729085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of growth and reduction in tumorigenicity of UCI-107 ovarian cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide.
    Chatzistamou I; Schally AV; Varga JL; Groot K; Armatis P; Bajo AM
    J Cancer Res Clin Oncol; 2001 Nov; 127(11):645-52. PubMed ID: 11710593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of the insulin-like growth factor axis during in vitro differentiation of the human osteosarcoma cell line HOS 58.
    Viereck V; Siggelkow H; Pannem R; Braulke T; Scharf JG; Kübler B
    J Cell Biochem; 2007 Sep; 102(1):28-40. PubMed ID: 17372931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone and insulin-like growth factor-I: effects on the growth of glioma cell lines.
    Friend KE; Khandwala HM; Flyvbjerg A; Hill H; Li J; McCutcheon IE
    Growth Horm IGF Res; 2001 Apr; 11(2):84-91. PubMed ID: 11472074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of proliferation, VEGF secretion of human neuroendocrine tumor cell line NCI-H727 by an antagonist of growth hormone-releasing hormone (GH-RH) in vitro.
    Sacewicz M; Lawnicka H; Siejka A; Stepień T; Krupiński R; Komorowski J; Stepień H
    Cancer Lett; 2008 Sep; 268(1):120-8. PubMed ID: 18486324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The monoclonal HBA-71 antibody modulates proliferation of thymocytes and Ewing's sarcoma cells by interfering with the action of insulin-like growth factor I.
    Hamilton G; Mallinger R; Hofbauer S; Havel M
    Thymus; 1991 Aug; 18(1):33-41. PubMed ID: 1656551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of tumor growth by growth hormone-releasing hormone antagonist JV-1-36 does not involve the inhibition of autocrine production of insulin-like growth factor II in H-69 small cell lung carcinoma.
    Kiaris H; Schally AV; Varga JL
    Cancer Lett; 2000 Dec; 161(2):149-55. PubMed ID: 11090963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonists of growth hormone releasing hormone (GHRH) and of bombesin/gastrin releasing peptide (BN/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF/HER family in PC-3 and DU-145 human androgen-independent prostate cancers.
    Stangelberger A; Schally AV; Varga JL; Hammann BD; Groot K; Halmos G; Cai RZ; Zarandi M
    Prostate; 2005 Aug; 64(3):303-15. PubMed ID: 15754342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin analog RC-160 inhibits the growth of human osteosarcomas in nude mice.
    Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K
    Int J Cancer; 1996 Mar; 65(6):870-4. PubMed ID: 8631606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mRNA expression patterns for GH, PRL, SL, IGF-I and IGF-II during altered feeding status in rabbitfish, Siganus guttatus.
    Ayson FG; de Jesus-Ayson EG; Takemura A
    Gen Comp Endocrinol; 2007 Jan; 150(2):196-204. PubMed ID: 16978626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.